Clinical Trials | December 04, 2025
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
Genomics is transforming the future of modern medicine and treatment modalities across specialties
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Nous-209 has been developed using the Nouscom's viral vector platform
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Subscribe To Our Newsletter & Stay Updated
